NKCC1 and hypertension: Role in the regulation of vascular smooth muscle contractions and myogenic tone

References

• Bianchi G, Ferrari P, Trizio P, Ferrandi M, Torielli L, Barber BR, . Red blood cell abnormalities and spontaneous hypertension in rats. A genetically determined link. Hypertension. 1985;7:319–25.
   PubMed Web of Science ®Google Scholar
• Kotelevtsev IuV, Orlov SN, Pokudin NI, Agnaev VM, Postnov IuV. [Genetic analysis of inheritance of Na+,K+ cotransport, calcium level in erythrocytes and blood pressure in F2 hybrids of spontaneously hypertensive and normotensive rats]. Bull Exp Biol Med. 1987;103:456–8.
   Google Scholar
• Orlov SN, Adragna N, Adarichev VA, Hamet P. Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol. 1999;276: C511–36.
   PubMed Web of Science ®Google Scholar
• Garay RP, Alda O. What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension. Pathophysiology. 2007;14:167–70.
   PubMedGoogle Scholar
• Jiang G, Akar F, Cobbs SL, Lomashvilli K, Lakkis R, Gordon FJ, . Blood pressure regulates the activity and function of Na-K-2Cl cotransporter in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2004;286:H1552–7.
   Google Scholar
• Orlov SN, Gossard F, Pausova Z, Akimova OA, Tremblay J, Grim CE, . Decreased NKCC1 activity in erythrocytes from African-Americans with hypertension and dyslipidemia. Am J Hypertens. 2010;23:321–6.
   PubMedGoogle Scholar
• Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev. 2005;85:423–93.
   PubMed Web of Science ®Google Scholar
• Orlov SN, Mongin AA. Salt sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol. 2007;293:H2039–53.
   PubMed Web of Science ®Google Scholar
• Orlov SN, Tremblay J, Hamet P. NKCC1 and hypertension: a novel therapeutic target involved in regulation of vascular tone and renal function. Curr Opin Nephrol Hypertens. 2010;19:163–8.
   PubMed Web of Science ®Google Scholar
• Chipperfield AR, Harper AA. Chloride in smooth muscle. Prog Biophys Mol Biol. 2001;74:175–221.
   Google Scholar
• Davis JPL, Chipperfield AR, Harper AA. Accumulation of intracellular chloride by (Na-K-Cl) cotransport in rat arterial smooth muscle is enhanced in deoxycorticosterone acetate (DOCA)/salt hypertension. J Mol Cell Cardiol. 1993;25: 233–7.
   PubMedGoogle Scholar
• Anfinogenova YJ, Baskakov MB, Kovalev IV, Kilin AA, Dulin NO, Orlov SN. Cell-volume-dependent vascular smooth muscle contraction: role of Na+, K+, 2Cl cotransport, intracellular Cl and L-type Ca2+ channels. Pflügers Archiv. 2004;449: 42–55.
   PubMedGoogle Scholar
• Barthelmebs M, Stephan D, Fontaine C, Grima M, Imbs JL. Vascular effects of loop diuretics: an in vivo and in vitro study in the rat. Naunyn-Schmiedebergs Arch Pharmacol. 1994;349: 209–16.
   PubMedGoogle Scholar
• Lavallee SL, Iwamoto LM, Claybaugh JR, Dressel MV, Sato AK, Nakamura KT. Furosemide-induced airway relaxation in guinea pigs: relation to Na-K-2Cl cotransporter function. Am J Physiol. 1997;273:L211–6.
   Google Scholar
• Tian R, Aalkjaer C, Andreasen F. Mechanisms behind the relaxing effect of furosemide on the isolated rabbit ear artery. Pharmacol Toxicol. 1990;67:406–10.
   PubMedGoogle Scholar
• Kovalev IV, Baskakov MB, Anfinogenova YJ, Borodin YL, Kilin AA, Minochenko IL, . Effect of Na +, K+, 2Cl cotransport inhibitor bumetanide on electrical and contractile activity of smooth muscle cells in guinea pig ureter. Bull Exp Biol Med. 2003;136:145–9.
   PubMedGoogle Scholar
• Kovalev IV, Baskakov MB, Medvedev MA, Minochenko IL, Kilin AA, Anfinogenova YJ, . Na + ,K + ,2Cl cotransport and chloride permeability of the cell membrane in mezaton and histamine regulation of electrical and contractile activity in smooth muscle cells from the guinea pig ureter. Russian Physiol J. 2008;93:306–17.
   Google Scholar
• Stanke F, Devillier P, Breant D, Chavanon O, Sessa C, Bricca G, . Furosemide inhibits angiotensin II-induced contraction on human vascular smooth muscle. Br J Clin Pharmacol. 1998;46:571–5.
   PubMed Web of Science ®Google Scholar
• Stanke-Labesque F, Craciwski JL, Bedouch P, Chavanon O, Magne JL, Bessard G, . Furosemide inhibits thrombaxane A2-induced contraction in isolated human internal artery and saphenous vein. J Cardiovasc Pharmacol. 2000;35: 531–7.
   PubMedGoogle Scholar
• Wang X, Breaks J, Loutzenhiser K, Loutzenhiser R. Effects of inhibition of the Na + /K + /2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole. Am J Physiol Renal Physiol. 2007;292:F999–1006.
   Google Scholar
• Mozhayeva MG, Bagrov YY. The inhibitory effects of furosemide on Ca2+ influx pathways associated with oxytocin-induced contractions of rat myometrium. Gen Physiol Biophys. 1995;14:427–36.
   PubMedGoogle Scholar
• Mozhayeva MG, Bagrov YY, Ostretsova IB, Gillespie JI. The effect of furosemide on oxytocin-induced contractions of the rat myometrium. Exp Physiol. 1994;79:661–7.
   PubMedGoogle Scholar
• Akar F, Skinner E, Klein JD, Jena M, Paul RJ, O'Neill WC. Vasoconstrictors and nitrovasodilators reciprocally regulate the Na + -K + -2Cl cotransporter in rat aorta. Am J Physiol. 1999;276:C1383–90.
   Google Scholar
• Garg P, Martin C, Elms SC, Gordon FJ, Wall SM, Garland CJ, . Effect of the Na-K-2Cl cotransporter NKCC1 on systematic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol. 2007;292:H2100–5.
   Google Scholar
• Palacios J, Espinoza F, Munita C, Cifuentes F, Michea L. Na + -K + -2Cl cotransporter is implicated in gender differences in the response of the rat aorta to phenylephrine. Br J Pharmacol. 2006;148:964–72.
   PubMedGoogle Scholar
• Koltsova SV, Maximov GV, Kotelevtsev SV, Lavoie JL, Tremblay J, Grygorczyk R, . Myogenic tone in mouse mesenteric arteries: evidence for P2Y receptor-mediated, Na + ,K + ,2Cl cotransport-dependent signaling. Purinergic Signal. 2009;5:343–9.
   PubMedGoogle Scholar
• Koltsova SV, Kotelevtsev SV, Tremblay J, Hamet P, Orlov SN. Excitation-contraction coupling in resistant mesenteric arteries: evidence for NKCC1-mediated pathway. Biochem Biophys Res Commun. 2009;379:1080–3.
   PubMedGoogle Scholar
• Meyer JW, Flagella M, Sutliff RL, Lorenz JN, Nieman ML, Weber GS, . Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na + -K + -2Cl cotransporter. Am J Physiol. 2002;283:H1846–55.
   Google Scholar
• Lee H-A, Baek I, Seok YM, Yang E, Cho H-M, Lee D-Y, . Promoter hypomethylation upregulates Na + -K + -2Cl cotransporter 1 in spontaneously hypertensive rats. Biochem Biophys Res Commun. 2010;396:252–7.
   PubMed Web of Science ®Google Scholar
• Yang S-S, Lo Y-F, Wu C-C, Lin S-W, Yeh C-J, Chu P, . SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol. 2010;21:1868–77.
   PubMed Web of Science ®Google Scholar
• Vitari AC, Thastrup J, Rafigi FH, Deak M, Morrice NA, Karlsson HK, . Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J. 2006;397:223–31.
   PubMed Web of Science ®Google Scholar
• Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andriga A, . Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem. 1999;274:26946–55.
   PubMed Web of Science ®Google Scholar
• Wall SM, Knepper MA, Hassel KA, Fischer MP, Shodeinde A, Shin W, . Hypotension in NKCC1 null mice: role of the kidney. Am J Physiol Renal Physiol. 2006;290:F409–16.
   Google Scholar
• Kim SM, Eisner C, Faulhaber-Walter R, Mizel D, Wall SM, Briggs JP, . Salt sensitivity of blood pressure in NKCC1-deficient mice. Am J Physiol Renal Physiol. 2008;295: F1230–8.
   Google Scholar
• Orlov SN, Resink TJ, Bernhardt J, Buhler FR. Na + -K + pump and Na + -K + co-transport in cultured vascular smooth muscle cells from spontaneously hypertensive rats: baseline activity and regulation. J Hypertens. 1992;10:733–40.
   PubMedGoogle Scholar
• Jiang G, Cobbs S, Klein JD, O'Neill WC. Aldosterone regulates the Na-K-Cl cotransporter in vascular smooth muscle. Hypertension. 2003;41:1131–5.
   PubMedGoogle Scholar
• Orlov SN, Li J-M, Tremblay J, Hamet P. Genes of intracellular calcium metabolism and blood pressure control in primary hypertension. Semin Nephrol. 1995;15:569–92.
   PubMedGoogle Scholar
• Hamet P, Orlov SN, Tremblay J. Intracellular signalling mechanisms in hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and treatment. New York: Raven Press; 1995. p. 575–608.
   Google Scholar
• Gagnon F, Delpire E. Multiple pathways for protein phosphatase 1 (PP1) regulation of Na-K-2Cl cotransporter (NKCC1) function: the N-terminal tail of the Na-K-2Cl cotransporter serves as a regulator scaffold for the Ste20-related proline/alanine-rich kinase (SPAK) and PP1. J Biol Chem. 2010;285:14115–21.
   PubMedGoogle Scholar
• Sid B, Miranda L, Vertommen D, Viollet B, Rider MH. Stimulation of human and mouse erythrocyte Na + -K + -2Cl- cotransport by osmotic shrinkage does not involve AMP-activated protein kinase, but is associated with STE20/SPS1-related proline/alanine-rick kinase activation. J Physiol. 2010;588:2315–28.
   PubMedGoogle Scholar
• Hannemann A, Flatman PW. Phosphorylation and transport in the Na-K-2Cl cotransporters, NKCC1 and NKCC2A, compared in HEK-293 cells. PLoS One. 2011;25:e17992.
   Google Scholar
• Bergaya S, Faure S, Baudrie V, Rio M, Escoubet B, Bonnin P, . WNK1 regulates vasoconstriction and blood pressure response to α1-adrenergic stimulation in mice. Hypertension. 2011;58:439–45.
   PubMed Web of Science ®Google Scholar
• Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, . Human hypertension caused by mutations in WNK kinases. Science. 2001;293: 1107–12.
   PubMed Web of Science ®Google Scholar
• San-Cristobal P, de los Heros P, Ponce-Coria J, Moreno T, Gamba G. WNK kinases, renal ion transport and hypertension. Am J Nephrol. 2008;28:860–70.
   PubMedGoogle Scholar
• Rafigi FH, Zuber AM, Glover M, Richardson C, Fleming S, Jovanovic A, . Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med. 2010;2:63–75.
   PubMedGoogle Scholar
• Cho H-M, Lee H-A, Kim HY, Han HS, Kim IK. Expression of Na + ,K + -2Cl cotransporter is epigenetically regulated during postnatal development of hypertension. Am J Hypertens. 2011;24:1286–93.
   PubMed Web of Science ®Google Scholar
• Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypothesis. Clin Sci. 1999;96:313–26.
   PubMed Web of Science ®Google Scholar
• Hill MA, Davis MJ, Meininger GA, Potocnik SJ, Murphy TV. Arteriolar myogenic signaling mechanisms: implications for local vascular functions. Clin Hemorheol Microcirc. 2006;34:67–79.
   PubMedGoogle Scholar
• Schubert R, Lidington D, Bolz S-S. The emerging role of Ca2 + sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res. 2008;77:8–18.
   PubMed Web of Science ®Google Scholar
• Loutzenhiser R, Bidani AK, Wang X. Systolic pressure and the myogenis response of the afferent arteriole. Acta Physiol Scand. 2004;181:407–13.
   PubMedGoogle Scholar
• Lagaud G, Gaudreault N, Moore EDW, Van Breemen C, Laher I. Pressure-dependent myogenic constriction of cefrebral arteries occurs independently of voltage-dependent activation. Am J Physiol Heart Circ Physiol. 2002;283: H2187–95.
   Google Scholar
• Adragna N, White RE, Orlov SN, Lauf PK. K-Cl cotransport in vascular smooth muscle and erythrocytes: possible implication in vasodilation. Am J Physiol. 2000;278:C381–90.
   Google Scholar
• Folkow B. Cardiovascular “remodeling” in rat and human: time axis, extent, and in vivo relevance. Physiology (Bethesda). 2010;25:264–5.
   PubMedGoogle Scholar
• Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153–67.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gutterman DD. Vascular control in humans: focus on the coronary micocirculation. Basic Res Cardiol. 2009;104: 211–27.
   PubMedGoogle Scholar
• Bidani A, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension. 2009;54:393–8.
   PubMed Web of Science ®Google Scholar
• Nathan S, Pepine CJ, Bakris GL. Calcium antagonists: effects on cardio-renal risk in hypertensive patients. Hypertension. 2005;46:637–42.
   PubMed Web of Science ®Google Scholar
• Griffin KA, Picken MM, Bakris GL, Bidani AK. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int. 1999;55:1849–60.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P, . Effect of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int. 2008;73:1303–9.
   PubMed Web of Science ®Google Scholar
• Shibata MC, Leon H, Chatterley T, Dorgan M, Vandermeer B. Do calcium channel blockers increase the diagnosis of heart failure with hypertension? Am J Cardiol. 2010;106: 228–35.
   PubMed Web of Science ®Google Scholar
• Loutzenhiser R, Epstein M. The renal hemodynamic effects of calcium antagonists. In: Epstein M, Loutzenhiser R, editors. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, Inc.; 1990. p. 33–74.
   Google Scholar
• Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, . T-type channel blockage as a determinant of kidney protection. Keio J Med. 2010;59:84–95.
   PubMedGoogle Scholar
• Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest. 2003;112:1895–905.
   PubMed Web of Science ®Google Scholar
• Hansen PB, Jensen BL, Andreasen D, Scott O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res. 2001;89: 630–8.
   PubMed Web of Science ®Google Scholar
• Orlov SN. Decreased Na + ,K + ,Cl cotransport and salt retention in Blacks: a provocative hypothesis. J Hypertens. 2005;23:1929–30.
   PubMedGoogle Scholar
• Boone CA. End-stage renal disease in African-Americans. Nephrol Nurs J. 2000;27:597–600.
   PubMedGoogle Scholar
• Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, . Glomerular hyperfiltration in hypertensive African Americans. Hypertension. 2000;35:822–6.
   PubMed Web of Science ®Google Scholar
• Orlov SN, Resink TJ, Bernhardt J, Buhler FR. Volume-dependent regulation of sodium and potassium fluxes in cultured vascular smooth muscle cells: dependence on medium osmolality and regulation by signalling systems. J Membrane Biol. 1992;126:199–210.
   Google Scholar
• Koltsova SV, Gusakova SV, Anfinogenova YJ, Baskakov MB, Orlov SN. Vascular smooth muscle contraction evoked by cell volume modulation: role of cytoskeleton network. Cell Physiol Biochem. 2008;21:29–36.
   PubMedGoogle Scholar
• Orlov SN, Hamet P. Intracellular monovalent ions as second messengers. J Membr Biol. 2006;210:161–72.
   PubMed Web of Science ®Google Scholar
• Hannaert P, Alvarez-Guerra M, Pirot D, Nazaret C, Garay RP. Rat NKCC2/NKCC1 cotransport selectivity for loop diuretic drugs. Naunyn-Schmiedebergs Arch Pharmacol. 2002;365:193–9.
   PubMedGoogle Scholar
• Delpire E, Lu J, England R, Dull C, Thorne T. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet. 1999;22: 192–5.
   PubMed Web of Science ®Google Scholar
• Lang F, Vallon V, Knipper M, Wangemann P. Functional significance of channels and transporters expressed in the inner ear and kidney. Am J Physiol Cell Physiol. 2007;293: C1187–208.
   PubMed Web of Science ®Google Scholar